Managing Menopause and Weight Gain
Navigating through menopause presents unique challenges, particularly in maintaining a healthy weight.
Source: dubaichronicle.com
📰 Allurion Program News
Page 2 - Allurion Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Allurion Program. Real-time updates on events, politics, business and more.
Allurion to Participate in Cowen's 44th Annual Health Care Conference
20.02.2024 - Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the 44th Annual Cowen Health Care Conference, taking place on March 4 – March 6, 2024 at the Marriott Copley Place in ...
United States Health Tracker Allurion Program Allurion Gastric Balloon Allurion Virtual Care Suite Allurion Mobile App
Source: wallstreet-online.de
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
NATICK, Mass.--(BUSINESS WIRE)--Feb 8, 2024--
Source: valdostadailytimes.com
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced the appointment of Brendan Gibbons as its new Chief Legal Officer and corporate secretary. Brendan joins...
United States Brendan Gibbons Carter Inc Exchange Commission Acushnet Company Allurion Technologies Inc
Source: marketscreener.com
World first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss -January 23, 2024 at 08:16 am EST
Allurion Program is the latest innovation in the NHS’s war against obesity ...
United States United Kingdom Richard Welbourn Henry Dimbleby Exchange Commission Tony Blair Institute
Source: marketscreener.com
Swallowable Balloon, Semaglutide Improve Obesity-Related OSA
The combined therapy of a swallowable weight-loss balloon and semaglutide oral formulation showed significant reductions in OSA.
Source: sleepreviewmag.com
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
Allurion Program led to resolution of type 2 diabetes, hypertension, and obstructive sleep apnea in just 4 months in over half of the patients treated Results improved with addition of oral GLP-1...
United States Mohit Bhandari Exchange Commission Allurion Technologies Inc Company Quarterly Report On Form Allurion Program
Source: marketscreener.com
Allurion Announces Preliminary Fourth Quarter and Full Year2023 Results and Provides 2024 Outlook
NATICK - Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced preliminary unaudited results for the fourth quarter and full year 2023. The Company also issued its...
United States Cedric Damour Brian Conyer Brian Ruby Exchange Commission Company Quarterly Report On Form
Source: marketscreener.com
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
Generated substantial procedure growth in 2023 driven by best-in-class efficacy of balloon program; prioritizing key investments in strategic markets and digital innovations ahead of FDA milestones ...
United States Brian Conyer Company Quarterly Report On Form Exchange Commission Allurion Program Allurion Technologies Inc
Source: marketscreener.com
Allurion's Digital Platform Gains Traction with Expanded Strategic Partnership -January 02, 2024 at 08:03 am EST
Company also announces addition of serial entrepreneur Brian Conyer to the team to lead commercialization of Allurion’s digital assets ...
Source: marketscreener.com